247 related articles for article (PubMed ID: 25186228)
21. Which outcomes have been measured in hand eczema trials? A systematic review.
Rönsch H; Apfelbacher C; Brans R; Matterne U; Molin S; Ofenloch R; Oosterhaven JAF; Schuttelaar MLA; Weisshaar E; Yew YW; Bauer A
Contact Dermatitis; 2019 Apr; 80(4):201-207. PubMed ID: 30632613
[TBL] [Abstract][Full Text] [Related]
22. Protocol for the development of a core domain set for hand eczema trials.
Rönsch H; Apfelbacher C; Brans R; Ofenloch R; Schuttelaar MLA; Weisshaar E; Bauer A
J Eur Acad Dermatol Venereol; 2020 Dec; 34(12):2871-2876. PubMed ID: 32274874
[TBL] [Abstract][Full Text] [Related]
23. Protocol of a scoping review of outcome domains in dermatology.
Nadir U; Ahmed A; Yi MD; Hisham FI; Dave L; Kottner J; Ezzedine K; Garg A; Ingram JR; Jemec GBE; Spuls PI; Kirkham JJ; Cahn B; Alam M
BMJ Open; 2024 Feb; 14(2):e079632. PubMed ID: 38320843
[TBL] [Abstract][Full Text] [Related]
24. Inconsistency and low transparency were found between core outcome set protocol and full text publication: a comparative study.
Liu M; Gao Y; Yuan Y; Shi S; Yang K; Lu C; Wu J; Zhang J; Tian J
J Clin Epidemiol; 2021 Mar; 131():59-69. PubMed ID: 33227446
[TBL] [Abstract][Full Text] [Related]
25. [Core outcome measurements in hand eczema trials : The HECOS initiative].
Rönsch H; Bauer A; Apfelbacher C
Hautarzt; 2019 Oct; 70(10):773-777. PubMed ID: 31359075
[TBL] [Abstract][Full Text] [Related]
26. Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative).
Chalmers JR; Simpson E; Apfelbacher CJ; Thomas KS; von Kobyletzki L; Schmitt J; Singh JA; Svensson Å; Williams HC; Abuabara K; Aoki V; Ardeleanu M; Awici-Rasmussen M; Barbarot S; Berents TL; Block J; Bragg A; Burton T; Bjerring Clemmensen KK; Creswell-Melville A; Dinesen M; Drucker A; Eckert L; Flohr C; Garg M; Gerbens LA; Graff AL; Hanifin J; Heinl D; Humphreys R; Ishii HA; Kataoka Y; Leshem YA; Marquort B; Massuel MA; Merhand S; Mizutani H; Murota H; Murrell DF; Nakahara T; Nasr I; Nograles K; Ohya Y; Osterloh I; Pander J; Prinsen C; Purkins L; Ridd M; Sach T; Schuttelaar ML; Shindo S; Smirnova J; Sulzer A; Synnøve Gjerde E; Takaoka R; Vestby Talmo H; Tauber M; Torchet F; Volke A; Wahlgren CF; Weidinger S; Weisshaar E; Wollenberg A; Yamaga K; Zhao CY; Spuls PI
Br J Dermatol; 2016 Jul; 175(1):69-79. PubMed ID: 27436240
[TBL] [Abstract][Full Text] [Related]
27. Report from the kick-off meeting of the Cochrane Skin Group Core Outcome Set Initiative (CSG-COUSIN).
Schmitt J; Deckert S; Alam M; Apfelbacher C; Barbaric J; Bauer A; Chalmers J; Chosidow O; Delamere F; Doney E; Eleftheriadou V; Grainge M; Johannsen L; Kottner J; Le Cleach L; Mayer A; Pinart M; Prescott L; Prinsen CA; Ratib S; Schlager JG; Sharma M; Thomas KS; Weberschock T; Weller K; Werner RN; Wild T; Wilkes SR; Williams HC
Br J Dermatol; 2016 Feb; 174(2):287-95. PubMed ID: 26779929
[TBL] [Abstract][Full Text] [Related]
28. Methods used in the selection of instruments for outcomes included in core outcome sets have improved since the publication of the COSMIN/COMET guideline.
Gorst SL; Prinsen CAC; Salcher-Konrad M; Matvienko-Sikar K; Williamson PR; Terwee CB
J Clin Epidemiol; 2020 Sep; 125():64-75. PubMed ID: 32470621
[TBL] [Abstract][Full Text] [Related]
29. The standards of obstetrics and gynecology core outcome sets: A scoping review.
Shi J; Gao Y; Wu S; Niu M; Chen Y; Yan M; Song Z; Feng H; Zhang J; Tian J
Integr Med Res; 2022 Mar; 11(1):100776. PubMed ID: 34745879
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the measurement properties of symptom measurement instruments for atopic eczema: a systematic review.
Gerbens LA; Prinsen CA; Chalmers JR; Drucker AM; von Kobyletzki LB; Limpens J; Nankervis H; Svensson Å; Terwee CB; Zhang J; Apfelbacher CJ; Spuls PI;
Allergy; 2017 Jan; 72(1):146-163. PubMed ID: 27322918
[TBL] [Abstract][Full Text] [Related]
31. How to use the Harmonising Outcome Measures for Eczema Core Outcome Set for atopic dermatitis trials: a users' guide.
Thomas KS; Howells L; Leshem YA; Simpson EL; Apfelbacher C; Spuls PI; Gerbens LAA; Jacobson ME; Katoh N; Williams HC; Stuart BL
Br J Dermatol; 2024 Mar; 190(4):527-535. PubMed ID: 38123134
[TBL] [Abstract][Full Text] [Related]
32. Measurement properties of patient-reported outcome measures for eczema control: a systematic review.
Stuart BL; Howells L; Pattinson RL; Chalmers JR; Grindlay D; Rogers NK; Grinich E; Pawlitschek T; Simpson EL; Thomas KS
J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):1987-1993. PubMed ID: 33977561
[TBL] [Abstract][Full Text] [Related]
33. TREatment of ATopic eczema (TREAT) Registry Taskforce: consensus on how and when to measure the core dataset for atopic eczema treatment research registries.
Vermeulen FM; Gerbens LAA; Bosma AL; Apfelbacher CJ; Irvine AD; Arents BWM; Barbarot S; Deleuran M; Eichenfield LF; Manca A; Schmitt J; Vestergaard C; Wall D; Weidinger S; Middelkamp-Hup MA; Spuls PI; Flohr C;
Br J Dermatol; 2019 Sep; 181(3):492-504. PubMed ID: 30719709
[TBL] [Abstract][Full Text] [Related]
34. Measurement properties of adult quality-of-life measurement instruments for eczema: a systematic review.
Heinl D; Prinsen CA; Deckert S; Chalmers JR; Drucker AM; Ofenloch R; Humphreys R; Sach T; Chamlin SL; Schmitt J; Apfelbacher C
Allergy; 2016 Mar; 71(3):358-70. PubMed ID: 26564008
[TBL] [Abstract][Full Text] [Related]
35. Developing a core outcome domain set to assessing effectiveness of interdisciplinary multimodal pain therapy: the VAPAIN consensus statement on core outcome domains.
Kaiser U; Kopkow C; Deckert S; Neustadt K; Jacobi L; Cameron P; De Angelis V; Apfelbacher C; Arnold B; Birch J; Bjarnegård A; Christiansen S; C de C Williams A; Gossrau G; Heinks A; Hüppe M; Kiers H; Kleinert U; Martelletti P; McCracken L; de Meij N; Nagel B; Nijs J; Norda H; Singh JA; Spengler E; Terwee CB; Tugwell P; Vlaeyen JWS; Wandrey H; Neugebauer E; Sabatowski R; Schmitt J
Pain; 2018 Apr; 159(4):673-683. PubMed ID: 29300277
[TBL] [Abstract][Full Text] [Related]
36. Development of a Core Outcome Set for Clinical Trials in Non-infectious Uveitis of the Posterior Segment.
Tallouzi MO; Mathers JM; Moore DJ; Bucknall N; Calvert MJ; Murray PI; Denniston AK;
Ophthalmology; 2021 Aug; 128(8):1209-1221. PubMed ID: 33515595
[TBL] [Abstract][Full Text] [Related]
37. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
38. Definition of treatment goals in terms of clinician-reported disease severity and patient-reported outcomes in moderate-to-severe adult atopic dermatitis: a systematic review.
Iannone M; Tonini G; Janowska A; Dini V; Romanelli M
Curr Med Res Opin; 2021 Aug; 37(8):1295-1301. PubMed ID: 34027753
[TBL] [Abstract][Full Text] [Related]
39. Standardizing serial photography for assessing and monitoring vitiligo: A core set of international recommendations for essential clinical and technical specifications.
van Geel N; Hamzavi I; Kohli I; Wolkerstorfer A; Lim HW; Bae JM; Lui H; Harris JE; Pandya AG; Thng Tien Guan S; Abdallah M; Esmat S; Seneschal J; Speeckaert R; Grine L; Kang HY; Raboobee N; Xiang LF; Bekkenk M; Picardo M; Taieb A
J Am Acad Dermatol; 2020 Dec; 83(6):1639-1646. PubMed ID: 31678332
[TBL] [Abstract][Full Text] [Related]
40. Representation of published core outcome sets in practice guidelines.
Rhodes S; Dodd S; Deckert S; Vasanthan L; Qiu R; Rohde JF; Florez ID; Schmitt J; Nieuwlaat R; Kirkham J; Williamson PR
J Clin Epidemiol; 2024 May; 169():111311. PubMed ID: 38423401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
